US 5195941A
· Erickson
· 1993
[cited by examiner]
US 5314401A
· Tepper
· 1994
[cited by examiner]
US 5478303A
· Foley-Nolan
· 1995
[cited by examiner]
US 6024691A
· Tepper
· 2000
[cited by examiner]
US 6443883B1
· Ostrow et al.
· 2002
[cited by applicant]
US 6463328B1
· John
· 2002
[cited by applicant]
US 9392956B2
· Luo et al.
· 2016
[cited by applicant]
US 9694197B2
· Segal
· 2017
[cited by applicant]
US 20040002635A1
· Hargrove et al.
· 2004
[cited by applicant]
US 20060122496A1
· George et al.
· 2006
[cited by applicant]
US 20060129022A1
· Venza
· 2006
[cited by examiner]
US 20090306491A1
· Haggers
· 2009
[cited by applicant]
US 20100210894A1
· Pascual-leone et al.
· 2010
[cited by applicant]
US 20120238835A1
· Hyde et al.
· 2012
[cited by applicant]
US 20140163304A1
· Burnett et al.
· 2014
[cited by applicant]
US 20140200388A1
· Schneider et al.
· 2014
[cited by applicant]
US 20140303425A1
· Pilla et al.
· 2014
[cited by applicant]
US 20150105837A1
· Aguilar Domingo
· 2015
[cited by applicant]
US 20150133718A1
· Schneider et al.
· 2015
[cited by applicant]
US 20150257700A1
· Fu
· 2015
[cited by applicant]
US 20150375005A1
· Segal
· 2015
[cited by applicant]
US 20160184599A1
· Segal
· 2016
[cited by applicant]
US 20160220836A1
· Parks
· 2016
[cited by applicant]
US 20170165485A1
· Sullivan
· 2017
[cited by examiner]
US 20180050216A9
· Burnett
· 2018
[cited by applicant]
US 20230372725A1
· Segal
· 2023
[cited by applicant]
CN 1457905
· 2003
[cited by applicant]
CN 1879906
· 2006
[cited by applicant]
CN 103917156
· 2014
[cited by applicant]
CN 104902806A
· 2015
[cited by applicant]
CN 107041750
· 2017
[cited by applicant]
CN 109906103
· 2019
[cited by applicant]
CN 110141780
· 2019
[cited by applicant]
CN 209253537
· 2019
[cited by applicant]
DE 202010005501
· 2010
[cited by examiner]
EP 2755550
· 2019
[cited by applicant]
JP 2007520290
· 2007
[cited by applicant]
JP 2014501582
· 2014
[cited by applicant]
JP 2014526336
· 2014
[cited by applicant]
KR 1020160007729
· 2016
[cited by applicant]
WO WO2004078260
· 2004
[cited by examiner]
WO 2011057028
· 2011
[cited by applicant]
WO 2013038400
· 2013
[cited by applicant]
WO 2015022679
· 2015
[cited by applicant]
WO 2015187712
· 2015
[cited by applicant]
WO 2016046830
· 2016
[cited by applicant]
WO 2018047164
· 2018
[cited by applicant]
WO WO2019161407
· 2019
[cited by applicant]
WO 2021117029
· 2021
[cited by applicant]
Notice of Reason(s) for Rejection Dated Jul. 23, 2024 From the Japan Patent Office Re. Application No. 2022-524662 and Its Translation Into English. (9 Pages).
[cited by applicant]
Notice of Allowance dated Sep. 27, 2022, which issued during the prosecution of U.S. Appl. No. 16/441,614.
[cited by applicant]
Notice of Allowance dated Oct. 21, 2022, which issued during the prosecution of Australian Patent Application No. 2017323663.
[cited by applicant]
An Office Action together with an English Summary dated Aug. 29, 2022 which issued during the prosecution of Korean Patent Application No. 10-2019-7009744.
[cited by applicant]
An Office Action together with an English Summary dated Oct. 17, 2022 which issued during the prosecution of Chinese Patent Application No. 10-2019-201780068350.3.
[cited by applicant]
Notice of Allowance Dated Apr. 7, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 16/330,670. (7 pages).
[cited by applicant]
Communication Pursuant to Article 94(3) EPC Dated Sep. 11, 2023 From the European Patent Office Re. Application No. 17848278.2. (4 Pages).
[cited by applicant]
Supplementary European Search Report and the European Search Opinion Dated Apr. 3, 2023 From the European Patent Office Re. Application No. 20899302.2. (7 Pages).
[cited by applicant]
U.S. Appl. No. 62/642,037, filed Mar. 13, 2018.
[cited by applicant]
Xiong, Ye, Asim Mahmood, and Michael Chopp. “Neurorestorative treatments for .traumatic brain injury.” Discovery medicine 10.54 (2010): 434.
[cited by applicant]
An International Search Report and a Written Opinion both dated Dec. 20, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050981.
[cited by applicant]
U.S. Appl. No. 62/946,762, filed Dec. 11, 2019.
[cited by applicant]
U.S. Appl. No. 62/946,754, filed Dec. 11, 2019.
[cited by applicant]
An English translation of an Office Action dated Jan. 27, 2016 which issued during the prosecution of Chinese Patent Application No. 201280055647.3.
[cited by applicant]
Niehaus, L., et al. “Abnormal postexcitatory and interhemispheric motor cortex .inhibition in writer's cramp.” Journal of neurology 248.1 (2001): 51-52.
[cited by applicant]
Rosenbaum, R. Shayna, et al. “The case of KC: contributions of a memory-.impaired person to memory theory.” Neuropsychologia 43.7 (2005): 989-1021.
[cited by applicant]
Emery, Gregory, et al. “Asymmetric Rab11 endosomes regulate delta recycling and specify cell fate in the
[cited by applicant]
Khanna, Michael J. “The cognitive correlates of human brain oscillations.” Journal .of Neuroscience 26.6 (2006): 1669-1672.
[cited by applicant]
Kernie, Steven G., Trent M. Erwin, and Luis F. Parada. “Brain remodeling due to neuronal and astrocytic proliferation after controlled cortical injury in mice.” .Journal of neuroscience research 66.3 (2001): 317-326.
[cited by applicant]
U.S. Appl. No. 62/642,038, filed Mar. 13, 2018.
[cited by applicant]
U.S. Appl. No. 61/533,917, filed Sep. 13, 2011.
[cited by applicant]
European Search Report dated Mar. 17. 2015, which issued during the prosecution of Applicant's European App No. 12831890.4.
[cited by applicant]
An International Search Report and a Written Opinion both dated Oct. 22. 2012, which issued during the prosecution of Applicant's PCT/IL2012/000255.
[cited by applicant]
An International Preliminary Report on Patentability dated Mar. 12, 2019, which issued during the prosecution of Applicant's PCT/IL2017/050981.
[cited by applicant]
An English translation of an Office Action dated May 28, 2015 which issued during the prosecution of Chinese Patent Application No. 201280055647.3.
[cited by applicant]
U.S. Appl. No. 62/747,671, filed Oct. 19, 2018.
[cited by applicant]
An English translation of an Office Action dated May 31, 2016, which issued during the prosecution of Japanese Patent Application No. 2014-530377.
[cited by applicant]
An English translation of an Office Action dated Mar. 7, 2017, which issued during the prosecution of Japanese Patent Application No. 2014-530377.
[cited by applicant]
An Office Action dated Jun. 1. 2016, which issued during the prosecution of U.S. Appl. No. 14/344,606.
[cited by applicant]
An Office Action dated Oct. 24, 2016, which issued during the prosecution of U.S. Appl. No. 14/344,606.
[cited by applicant]
Nithianandasivam, Nartani. “Oligodendrocytes, Myelin and Multiple Sclerosis.” .(2018) University of Toronto Medical Journal 95.1.
[cited by applicant]
An Office Action dated Jun. 29, 2018, which issued during the prosecution of U.S. Appl. No. 15/257,900.
[cited by applicant]
Notice of Allowance dated Apr. 10, 2019, which issued during the prosecution of U.S. Appl. No. 15/257,900.
[cited by applicant]
Notice of Allowance dated Feb. 28, 2019, which issued during the prosecution of U.S. Appl. No. 15/257,900.
[cited by applicant]
Notice of Allowance dated Mar. 20, 2017, which issued during the prosecution of U.S. Appl. No. 14/344,606.
[cited by applicant]
Notice of Allowance dated Apr. 5, 2017, which issued during the prosecution of Australian Patent Application No. 2012310074.
[cited by applicant]
An Office Action dated Apr. 15, 2016, which issued during the prosecution of Australian Patent Application No. 2012310074.
[cited by applicant]
An Office Action dated Mar. 28, 2018, which issued during the prosecution of Canadian Patent Application No. 2,848,549.
[cited by applicant]
An English Translation of an Office Action dated Oct. 19, 2017, which issued during the prosecution of Israel Patent Application No. 231486. (the relevant part only).
[cited by applicant]
Mantovani, Lorenzo Giovanni, et al. “Tecfidera® (delayed-release dimethylfumarate) in the treatment of relapsing-remitting multiple sclerosis.” Farmeconomia. Health economics and therapeutic pathways 18.2S (2017).
[cited by applicant]
Maynard, Frederick M., et al. “International standards for neurological and functional classification of spinal cord injury.” Spinal cord 35.5 (1997): 266-274.
[cited by applicant]
European Search Report dated Mar. 13, 2020, which issued during the prosecution of Applicant's European App No. 17848278.2.
[cited by applicant]
An Office Action dated Feb. 17. 2020, which issued during the prosecution of Indian Patent Application No. 2133/DELNP/2014.
[cited by applicant]
Elhalel, G., et al. “Cardioprotection from stress conditions by weak magnetic fields .in the Schumann Resonance band.” Scientific reports 9.1 (2019): 1-10.
[cited by applicant]
Lee, Hae Ung, et al. “Subcellular electrical stimulation of neurons enhances the .myelination of axons by oligodendrocytes.” PloS one 12.7 (2017): e0179642.
[cited by applicant]
An International Search Report and a Written Opinion both dated Mar. 26, 2021, which issued during the prosecution of Applicant's PCT/IL2020/051193.
[cited by applicant]
An Office Action dated Dec. 4, 2020 which issued during the prosecution of Applicant's European App No. 17848278.2.
[cited by applicant]
Cichon, Natalia, et al. “Increase in blood levels of growth factors involved in the neuroplasticity process by using an extremely low frequency electromagnetic field in post-stroke patients.” Frontiers in Aging Neurosci…
[cited by applicant]
Cichoń, Natalia, et al. “Benign effect of extremely low-frequency electromagnetic field on brain plasticity assessed by nitric oxide metabolism during poststroke rehabilitation.” Oxidative Medicine and Cellular Longevit…
[cited by applicant]
Ramos-Cejudo, Jaime, et al. “Traumatic brain injury and Alzheimer's disease: the .cerebrovascular link.” EBioMedicine 28 (2018): 21-30.
[cited by applicant]
Ross, Christina L., and Benjamin S. Harrison. “Effect of pulsed electromagnetic field on inflammatory pathway markers in RAW 264.7 murine macrophages.” .Journal of inflammation research 6 (2013): 45.
[cited by applicant]
Shih, Yao-Hsiang, et al. “Hypertension accelerates Alzheimer's disease-related .pathologies in pigs and 3xTg mice.” Frontiers in aging neuroscience 10 (2018): 73.
[cited by applicant]
Sorensen, Per Soelberg, and Morten Blinkenberg. “The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future .prospects.” Therapeutic advances in neurological disorders 9.1 (20…
[cited by applicant]
Zeilig, G., Gaidukov, E., Tavor, I., Livny, A., Alter, A., & Segal, Y. (2018). A Beneficial Effect Of A Brain Computer Interface Based Stimulation Device Aimed At Spinal Cord Injury Patients Impaired Neural Networks Imp…
[cited by applicant]
Wang, Shiqian, et al. “Design and control of the MINDWALKER exoskeleton.” IEEE transactions on neural systems and rehabilitation engineering 23.2 (2014): .277-286.
[cited by applicant]
Yakir-Blumkin, M. Ben, et al. “Neuroprotective Effect of Weak Static Magnetic Fields in Primary Neuronal Cultures.” .Neuroscience 278 (2014): 313-326.
[cited by applicant]
An Office Action dated Aug. 17, 2021, which issued during the prosecution of U.S. Appl. No. 16/330,670.
[cited by applicant]
Fotiou, D. F., et al. “Cholinergic deficiency in Alzheimer's and Parkinson's disease: Evaluation with pupillometry.” International Journal of Psychophysiology .73 (2009): 143-149.
[cited by applicant]
Gamito, Pedro, et al. “Cognitive training on stroke patients via virtual reality-based .serious games.” Disability and rehabilitation 39.4 (2017): 385-388.
[cited by applicant]
Westerberg, H., et al. “Computerized working memory training after stroke—.A pilot study.” Brain Injury 21.1 (2007): 21-29.
[cited by applicant]
Gravanis, Iordanis, and Stella E. Tsirka. “tPA as a therapeutic target in stroke.” .(2008) Expert opinion on therapeutic targets 12.2.
[cited by applicant]
Kirshblum, Steven C., et al. “International standards for neurological classification of spinal cord injury (Revised 2011).” The Journal of Spinal Cord Medicine 34.6 .(2011): 535.
[cited by applicant]
An Office Action dated Feb. 3, 2022, which issued during the prosecution of U.S. Appl. No. 16/330,670.
[cited by applicant]
An Office Action dated Mar. 25, 2022, which issued during the prosecution of U.S. Appl. No. 16/330,670.
[cited by applicant]
An English translation of an Office Action dated Jul. 6, 2021, which issued during the prosecution of Japanese Patent Application No. 2019-533724.
[cited by applicant]
An English translation of an Office Action dated Mar. 29, 2022, which issued during the prosecution of Japanese Patent Application No. 2019-533724.
[cited by applicant]
An Office Action dated Mar. 29, 2022, which issued during the prosecution of U.S. Appl. No. 16/441,614.
[cited by applicant]
Malone, Misti, et al. “Neuronal activity promotes myelination via a cAMP .pathway.” Glia 61.6 (2013): 843-854—Abstract.
[cited by applicant]
Hojati, Zohreh, Maryam Kay, and Fariba Dehghanian. “Mechanism of action of interferon beta in treatment of multiple sclerosis.” Multiple sclerosis. Academic Press, 2016. 365-392—Abstract accessed on Aug. 28, 2022 {.http…
[cited by applicant]
Johnson, Jon W., and Shawn E. Kotermanski. “Mechanism of action of memantine.” Current opinion in pharmacology 6.1 (2006): 61-67 Abstract accessed on Aug. 28, 2022 {https://www.sciencedirect.com/science/article/abs/pii/…
[cited by applicant]
Langhorne, Peter, Robert Wagenaar, and Cecily Partridge. “Physiotherapy after stroke: more is better?.” Physiotherapy Research International 1.2 (1996): 75-88—Abstract accessed on Aug. 28, 2022 {https://onlinelibrary.wi…
[cited by applicant]
Confavreux, Christian, and Sandra Vukusic. “The clinical course of multiple sclerosis.” Handbook of clinical neurology 122 (2014): 343-36988—Abstract accessed on Aug. 28, 2022 {https://www.sciencedirect.com/science/arti…
[cited by applicant]
An International Preliminary Report on Patentability dated May 17, 2022, which issued during the prosecution of Applicant's PCT/IL2020/051193.
[cited by applicant]
Grassi, Guido, et al. “Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials.” Current Hypertension Reports 4.9 (2007): 299-304—Abstract accessed on Aug. 28, 2022 {https://www.infon…
[cited by applicant]
An Office Action dated Oct. 20, 2021, which issued during the prosecution of Australian Patent Application No. 2017323663.
[cited by applicant]
An Office Action dated Jul. 27, 2021, which issued during the prosecution of Indian Patent Application No. 201917013336.
[cited by applicant]
Rudick, Richard A., and Susan E. Goelz. “Beta-interferon for multiple sclerosis.” .Experimental cell research 317.9 (2011): 1301-1311—Abstract.
[cited by applicant]
Seltzer, Ben. “Donepezil: a review.” Expert opinion on drug metabolism & toxicology 1.3 (2005): 527-536—Abstract accessed on Aug. 28, 2022 .{https://www.tandfonline.com/doi/abs/10.1517/17425255.1.3.527}.
[cited by applicant]
U.S. Appl. No. 63/079,496, filed Sep. 17, 2020.
[cited by applicant]
U.S. Appl. No. 63/183,112, filed May 3, 2021.
[cited by applicant]
U.S. Appl. No. 63/071,599, filed Aug. 28, 2020.
[cited by applicant]
Requisition by the Examiner Dated Oct. 16, 2023 From the Innovation, Science and Economic Development Canada, Canadian Intellectual Property Office Re. Application No. 3,034,752. (5 Pages).
[cited by applicant]
English Summary Dated May 15, 2023 of Notification of Office Action Dated May 6, 2023 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201780068350.3. (2 pages).
[cited by applicant]
Communication Pursuant to Article 94(3) EPC Dated Jun. 13, 2025 From the European Patent Office Re. Application No. 20899302.2 (9 Pages).
[cited by applicant]
Decision on Rejection Dated Jul. 27, 2023 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201780068350.3. (5 Pages).
[cited by applicant]
Hearing Notice Dated Jan. 11, 2024 From the Government of India, Intellectual Property India, The Patent Office Re. Application No. 201917013336. (2 Pages).
[cited by applicant]
Hearing Notice Dated Jan. 12, 2024 From the Government of India, Intellectual Property India, The Patent Office Re. Application No. 2133/DELNP/2014. (4 Pages).
[cited by applicant]
Notice of Reason for Rejection Dated Mar. 7, 2017 From the Japan Patent Office Re. Application No. 2014-530377. (4 Pages).
[cited by applicant]
Notice of Reason for Rejection Dated May 23, 2016 From the Japan Patent Office Re. Application No. 2014-530377. (4 Pages).
[cited by applicant]
Notification of Decision of Grant Dated Oct. 17, 2017 From the Japan Patent Office Re. Application No. 2014-530377. (3 Pages).
[cited by applicant]
English Summary Dated Aug. 8, 2023 of Decision on Rejection Dated Jul. 27, 2023 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201780068350.3. (3 pages).
[cited by applicant]
Machine Translation Dated Aug. 14, 2023 of Decision on Rejection Dated Jul. 27, 2023 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201780068350.3. (5 pages).
[cited by applicant]
Communication Pursuant to Article 94(3) EPC Dated Jul. 25, 2017 From the European Patent Office Re. Application No. 12831890.4 (3 Pages).
[cited by applicant]
Grounds of Reason of Rejection Dated Dec. 19, 2018 From the Korean Intellectual Property Office Re. Application No. 10-2001897 (6 pages).
[cited by applicant]
International Preliminary Report on Patentability Dated Mar. 18, 2014 From the International Bureau of WIPO Re. Application No. PCT/IL2012/000255. (5 Pages).
[cited by applicant]
Notification of Office Action and Search Report Dated Oct. 17, 2022 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201780068350.3 and its Summary in English. (10 Pages).
[cited by applicant]
Notification of Office Action Dated Jan. 27, 2016 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201280055647.3 (3 pages).
[cited by applicant]
Notification of Office Action Dated May 28, 2015 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201280055647.3. (4 pages).
[cited by applicant]
Translation of Notification of Office Action and Search Report Dated Oct. 17, 2022 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201780068350.3. (6 Pages).
[cited by applicant]
Notification of Office Action Dated May 6, 2023 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 201780068350.3. (5 Pages).
[cited by applicant]
Examination Report Dated Aug. 11, 2025 From the Australian Government, IP Australia Re. Application No. 2020399308. (5 Pages).
[cited by applicant]
Examination Report Under Sections 12 & 13 of the Patents Act, 1970 and the Patents Rules, 2003 Dated Sep. 24, 2025 From the Government of India, Intellectual Property India, Patents, Designs, Trade Marks, Geographical I…
[cited by applicant]
Notification of Office Action and Search Report Dated Oct. 28, 2025 From the State Intellectual Property Office of the People's Republic of China Re. Application No. 202080073123.1 with Its Summary and Machine Translati…
[cited by applicant]
Requisition by the Examiner Dated Nov. 13, 2025 From the Innovation, Science and Economic Development Canada, Canadian Intellectual Property Office Re. Application No. 3,152,608. (6 Pages).
[cited by applicant]